Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Titel:
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Auteur:
Shi, Y. Dong, M. Hong, X. Zhang, W. Feng, J. Zhu, J. Yu, L. Ke, X. Huang, H. Shen, Z. Fan, Y. Li, W. Zhao, X. Qi, J. Huang, H. Zhou, D. Ning, Z. Lu, X.